• The abstract submission for ICHNO 2024 is open as of early September 2023. The submission deadline is on 11 October 2023 (23h59 CET). 
  • Abstracts must be submitted online via the ESTRO website at
  • We highly recommend completing your submission early to avoid technical delays due to server overload close to the deadline
  • For questions regarding the submission process, please e-mail



The submitting author of an abstract: 

  • Accepts responsibility for the accuracy of the abstract and ascertains that all authors are aware of the content before submission.
  • Accepts to be the contact person for all correspondence related to the abstract and to inform the co-authors about its status.
  • Confirms that all authors contributing to the abstract are properly included in the author list.
  • Accepts to disclose any financial interest in products or processes described in the abstract. This includes stock ownership, membership on any advisory boards, commercially sponsored research or any other substantial relationships.  
  • Certifies that, if the abstract is selected, the information reported is for the exclusive presentation in the scientific programme and will not be presented at any commercially-sponsored satellite symposia during the congress.  
  • Abstracts are embargoed until 1 month prior to the congress at which point the abstract book is published on the website and abstracts are included in the online searchable programme. Should you wish for an abstract to be embargoed until the congress, please email by 4 February 2024. 
  • Abstracts must be submitted and presented in English. The Scientific Programme Committee reserves the right to reject an abstract written in poor English. 
  • Accepts that no edits to the abstract or author list are possible after the submission deadline of 11 October 2023.
  • Accepts to check the abstract overview provided in the submission confirmation email and ensure all abstract details are correct.



  • Please note that abstracts are reviewed by experts in the topic chosen.
  • Submitting to the wrong topic may result in your abstract receiving a lower score.


  • Choose the topic category that refers to the main subject of the abstract. The Scientific Programme Committee reserves the right to re-categorise the abstract.

  • Epidemiology and prevention
  • Imaging, radiomics and artificial intelligence
  • HPV or EBV related cancers
  • Innovative treatments
  • Minimal invasive and reconstructive surgery
  • Multidisciplinary management
  • Biology and molecular targeting
  • Immuno-oncology
  • Supportive care, rehabilitation
  • Salivary gland, skull base, skin and thyroid cancers
  • Management of elderly or frail patients
  • Quality of life and outcomes


  • Authors are required to write 1 to 3 keywords (different from the topic) that best describe their work. 



  • Authors should indicate if they want an abstract to ONLY be considered for a Digital Poster.
  • Please note that opting for “digital poster” will mean that your abstract will not be considered for a live proffered paper by the Scientific Programme Committee.
  • Not selecting "digital poster only" does not guarantee selection for a live presentation and the abstract may still be assigned as a digital poster.




  • Abstract titles should be brief and reflect the content of the abstract
  • The title (maximum 100 characters) is important since it focuses attention (it is the “showcase” for the presentation).
  • Do not use capital letters in the title except for words that are always capitalised and do not use non-standard abbreviations.
  • Prospective clinical trials should be identified as such in the title of the abstract (include The National Clinical Trial number when applicable) 


  • Abstracts are limited to 750 words.
  • Abstracts should be structured in such a way as to include:
  1. Purpose/Objective
  2. Material/Methods
  3. Results
  4. Conclusion
  5. References (not included in word count)


  • Abstracts on research obviously not yet performed and results not yet obtained will be rejected.
  • Case studies will not be considered (unless if first-in-human) .
  • Systematic reviews are accepted but literature reviews are not.
  • Papers already presented at another meeting will not be considered, unless the previous audience is distinct from the ICHNO 2024 congress audience (e.g. national meetings).  
  • Abstracts should include new information and not solely include materials already published. 
  • If very similar abstracts are submitted by the same authors, the Scientific Programme Committee reserves the right to select only one of the abstracts and reject any others. 



  • The use of standard abbreviations is desirable. A special or unusual abbreviation must be placed (in round brackets) after the first appearance of the word for which it stands.  
  • Tables and images may be included in an abstract but must be limited to two uploads (tables or images) in JPG or PNG formats. These uploads are not included in the character count. The maximum pixel size of an image is 600(w) x 800 (h) pixel. Larger images will not be properly visible in the abstract. Please ensure the content of the image is readable at this size. Abstracts containing multiple tables or figures within one image upload will be penalised during the review process.
  • Authors may include one data table using the insert table icon (we advise not to copy-paste a table into the body of the abstract). The characters in a data table are included in the character count.  
  • Equations can be inserted in the text as images.  
  • Once you have submitted an abstract, you will receive a confirmation email. Please click the link to the abstract overview to check your abstract has no errors or omissions and is complete (has all necessary sections filled and does not exceed the word count).
  • Only completed abstracts will be considered by the Committee for inclusion in the scientific programme.



  • Abstracts can be edited until the submission deadline of 11 October 2023.
  • Any changes to abstract are not accepted after this date. 
  • Please ensure all authors are included in the list and appear correctly in the abstract overview.
  • After editing, you will receive a notification email containing a link for the overview of the amended abstract. Please click on this link and check the abstract has no errors or omissions and is complete (has all necessary sections filled and does not exceed the word count).
  • Only completed abstracts will be considered by the Committee for inclusion in the scientific programme.



  • Abstracts submitted for presentation will be peer-reviewed by an international panel of experts in the field of the subject.  
  • Abstract review criteria are based on clarity, supporting data, scientific rigour, potential significance, interest in the topic chosen and innovation or usefulness.
  • Abstract scores will guide the Scientific Programme Committee in selecting the abstracts for the different presentation formats.
  • Notifications of abstract selection will be sent early December 2023.
  • Please note that acceptance of an abstract does not entitle the authors to a complimentary registration. Presenting authors should register for the congress by the early registration deadline.



  • Abstracts selected for Proffered Paper comprise a PowerPoint presentation of 7 minutes with 3 minutes for discussion.
  • Abstracts selected for Digital Poster are included in the digital poster gallery where they are grouped by topic and are displayed onsite and in the online platform.



  • Submitted abstracts can be withdrawn until 8 November 2023.
  • To withdraw your abstract, you should send an email to
  • After this date, withdrawal of abstracts is no longer possible.
  • If the presenting author cannot attend the congress, they should nominate a co-author and inform the ESTRO office as soon as possible.